International Journal of Endocrinology and Metabolism

Published by: Kowsar

Precision Medicine for Endocrinology

Fereidoun Azizi 1 , *
Author Information
1 Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of Endocrinology and Metabolism: July 01, 2016, 14 (3); e40283
  • Published Online: July 31, 2016
  • Article Type: Editorial
  • Received: July 10, 2016
  • Accepted: July 15, 2016
  • DOI: 10.5812/ijem.40283

To Cite: Azizi F. Precision Medicine for Endocrinology, Int J Endocrinol Metab. 2016 ;14(3):e40283. doi: 10.5812/ijem.40283.

Copyright © 2016, Research Institute For Endocrine Sciences and Iran Endocrine Society. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
References
  • 1. A Framework for Developing a New Taxonomy of Disease, Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. 2011;
  • 2. Jain KK. Textbook of personalized medicine. 2009;
  • 3. Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med. 2012; 366(6): 489-91[DOI][PubMed]
  • 4. Jameson JL, Longo DL. Precision medicine--personalized, problematic, and promising. N Engl J Med. 2015; 372(23): 2229-34[DOI][PubMed]
  • 5. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015; 372(9): 793-5[DOI][PubMed]
  • 6. Diabetes facts. 2015;
  • 7. CDC . National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. 2014;
  • 8. Naghavi M, Shahraz S, Sepanlou SG, Dicker D, Naghavi P, Pourmalek F, et al. Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010. Arch Iran Med. 2014; 17(5): 321-35[PubMed]
  • 9. Stolar MW. Defining and achieving treatment success in patients with type 2 diabetes mellitus. Mayo Clin Proc. 2010; 85(12 Suppl)-9[DOI][PubMed]
  • 10. Ahima RS. Editorial: Rethinking the definition of diabetes for precision medicine. Mol Endocrinol. 2015; 29(3): 335-7[DOI][PubMed]
  • 11. Klonoff DC. Precision medicine for managing diabetes. J Diabetes Sci Technol. 2015; 9(1): 3-7[DOI][PubMed]
  • 12. Azizi F, Amouzegar A. Management of hyperthyroidism during pregnancy and lactation. Eur J Endocrinol. 2011; 164(6): 871-6[DOI][PubMed]
  • 13. Chen PL, Fann CS, Shih SR, Yang WS, Chang TC. First step towards precision medicine for antithyroid drug-induced agranulocytosis. Lancet Diabetes Endocrinol. 2016; 4(6): 473-4[DOI][PubMed]
  • 14. Zhang XD. Precision Medicine. Pers Med. 2015; 6: 144
  • 15. Pawlyk AC, Giacomini KM, McKeon C, Shuldiner AR, Florez JC. Metformin pharmacogenomics: current status and future directions. Diabetes. 2014; 63(8): 2590-9[DOI][PubMed]
  • 16. Bayer R, Galea S. Public Health in the Precision-Medicine Era. N Engl J Med. 2015; 373(6): 499-501[DOI][PubMed]
  • 17. Groop L. Genetics and neonatal diabetes: towards precision medicine. Lancet. 2015; 386(9997): 934-5[DOI][PubMed]
  • 18. Ladenson PW. Precision Medicine Comes to Thyroidology. J Clin Endocrinol Metab. 2016; 101(3): 799-803[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments